zeleciment basivarsen
zeleciment basivarsen: 1 clinical trial tracked.
zeleciment basivarsen evidence translation
What we can confirm
1 tracked trial
No verified listed developer
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about zeleciment basivarsen, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence0 indications · 1 study sponsors
Related indications
No linked indication is available.
Study sponsors
Clinical Trials (1)
A Phase 3, Randomized, Double-Blind, 48-Week Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of DYNE-101 Administered to Participants With Myotonic Dystrophy Type 1
Primary endpoint: 5 Times Sit-To-Stand (5×STS) Time
InterventionalRandomizedquadruple150 targetStarted 2026-05Completion 2029-0134 sites · Belgium, Denmark, France, Germany…Dyne Therapeutics